Q3 2025 Holdings
Filed 2025-11-14 | 91 holdings | $958.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $48.0M | 80,000 | 5.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $42.4M | 434,377 | 4.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $40.0M | 87,690 | 4.2% |
| Insulet Corp(PODD) | COM | 45784P101 | $35.9M | 116,238 | 3.7% |
| CVS Health Corp(CVS) | COM | 126650100 | $28.6M | 379,486 | 3.0% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $26.1M | 671,592 | 2.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $24.9M | 1,154,487 | 2.6% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $24.8M | 251,420 | 2.6% |
| Stryker Corporation(SYK) | COM | 863667101 | $23.7M | 64,108 | 2.5% |
| Qiagen NV(QGEN) | COM SHS | N72482206 | $22.3M | 500,159 | 2.3% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $22.0M | 28,542 | 2.3% |
| Danaher Corporation(DHR) | COM | 235851102 | $21.9M | 110,541 | 2.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $21.1M | 1,735,003 | 2.2% |
| Uniqure NV(QURE) | SHS | N90064101 | $20.2M | 345,356 | 2.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $19.9M | 141,822 | 2.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $18.2M | 130,165 | 1.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $17.3M | 455,523 | 1.8% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $15.9M | 843,502 | 1.7% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $15.1M | 74,330 | 1.6% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $14.6M | 1,791,674 | 1.5% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $14.4M | 275,811 | 1.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $13.5M | 773,304 | 1.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $13.3M | 1,687,318 | 1.4% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $13.1M | 178,970 | 1.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $13.0M | 846,899 | 1.4% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $12.4M | 202,363 | 1.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $12.3M | 149,848 | 1.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $12.1M | 155,766 | 1.3% |
| Cooper COS Inc(COO) | COM | 216648501 | $12.1M | 176,523 | 1.3% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $11.6M | 306,027 | 1.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $11.5M | 171,628 | 1.2% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $10.8M | 475,568 | 1.1% |
| Optimizerx Corp(OPRX) | COM NEW | 68401U204 | $10.4M | 509,611 | 1.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $10.4M | 120,190 | 1.1% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $10.1M | 696,980 | 1.1% |
| Artivion Inc(AORT) | COM | 228903100 | $9.4M | 221,044 | 1.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $9.2M | 22,000 | 1.0% |
| Axogen Inc(AXGN) | COM | 05463X106 | $9.0M | 501,832 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $8.9M | 550,173 | 0.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $8.9M | 652,680 | 0.9% |
| Incyte Corp(INCY) | COM | 45337C102 | $8.5M | 100,442 | 0.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $8.1M | 339,764 | 0.8% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $8.0M | 402,595 | 0.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $8.0M | 40,343 | 0.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $7.9M | 579,174 | 0.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $7.7M | 1,012,664 | 0.8% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $7.7M | 223,065 | 0.8% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $7.6M | 10,000 | 0.8% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $7.4M | 252,817 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.1M | 176,137 | 0.7% |